The UTI PLUS panel includes all the organisms detected by the UTI w/AMR panel, such as Enterococcus spp., Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Staphylococcus aureus, Staphylococcus saprophyticus, Pseudomonas aeruginosa, Candida species (Candida albicans, Candida parapsilosis, Candida tropicalis), Citrobacter species (Citrobacter braakii/freundii, Citrobacter koseri), Enterobacter cloacae, Klebsiella species (Klebsiella aerogenes, Klebsiella oxytoca/michiganensis), Proteus vulgaris, Streptococcus agalactiae (Group B), and Ureaplasma urealyticum. It further extends detection to include Acinetobacter baumannii, Bacteroides fragilis, Candida species (Candida dubliniensis, Candida glabrata, Candida krusei), Morganella morganii, Providencia stuartii, Serratia marcescens, Staphylococcus epidermidis, and Streptococcus pyogenes (Group A).
In addition to pathogen detection, this panel screens for an extensive range of resistance genes, including those for sulfonamides, trimethoprim, erythromycin, SHV, TEM, CTX, tetracycline, fluoroquinolones, AmpC, blaKPC, blaCTX-M, blaFEC-1, and blaNDM. This comprehensive resistance profiling enables healthcare providers to identify antibiotic-resistant strains and tailor treatments effectively.
The Express Gene™ UTI PLUS test offers a thorough and reliable solution for diagnosing UTIs and managing antimicrobial resistance. With its extensive coverage and precise detection capabilities, it is an invaluable tool for clinicians aiming to provide the best care for their patients by ensuring accurate diagnosis and appropriate treatment of complex urinary tract infections.
